China Shineway Pharmaceutical Group Limited
CSWYY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $7 | $6 | $6 | $6 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$6 | -$6 | -$6 | -$5 |
| Revenue | $0 | $0 | – | $2 |
| % Growth | -3.3% | – | – | – |
| Gross Profit | $0 | $0 | – | $2 |
| % Margin | 72.2% | 74.5% | – | 75.1% |
| EBITDA | $0 | $0 | – | $0 |
| % Margin | 51.7% | 21.3% | – | 21.9% |
| Net Income | $0 | $0 | – | $0 |
| % Margin | 37.2% | 12.6% | – | 22.6% |
| EPS Diluted | 44.8 | 15.8 | – | 253.2 |
| % Growth | 183.5% | – | – | – |
| Operating Cash Flow | $0 | $0 | – | $1 |
| Capital Expenditures | -$0 | -$0 | – | -$0 |
| Free Cash Flow | $0 | $0 | – | $1 |